Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This article explains what is known today, why online prices should be treated with caution, and how retatrutide differs from FDA-approved GLP-1 and incretin-based medications that do have commercial pricing
Ozempic and Wegovy both contain semaglutide and are manufactured by Novo Nordisk
These officebased prices are still far below the national list price of brandname obesity drugs, but they're significant recurring expenses
162,163 Retatrutide (LY-3437943), a novel triple agonist developed by Eli Lilly that targets GLP-1R, GIPR and GCGR, has shown potential in preliminary clinical data for providing excellent blood sugar control and significant weight reduction
